Answer to Question 1
Correct Answer: 2
Rationale: Epoetin alfa therapy results in a slow rise in hematocrit at a rate of about 2 per week.
Global Rationale: Epoetin alfa therapy results in a slow rise in hematocrit at a rate of about 2 per week.
Answer to Question 2
Correct Answer: 2,4
Rationale 1: Since the client has been hospitalized for pharmacologic treatment, the need for multiple blood transfusions is unlikely.
Rationale 2: Many of the medications given for hematopoietic disorders either are identical to or closely resemble substances produced in the body.
Rationale 3: The medications do reverse the actions of chemotherapy against good cells, but this is a poor answer to the client and may cause undue stress.
Rationale 4: A simple statement of the action of the medications that will be administered, along with the reason they are being given, is a good response to this client's concerns.
Rationale 5: Chemotherapy is cytotoxic to rapidly proliferating cells such as blood cells. There is no reason to give radiation treatments to further decrease those cells.
Global Rationale: Many of the medications given for hematopoietic disorders either are identical to or closely resemble substances produced in the body. A simple statement of the action of the medications that will be administered, along with the reason they are being given, is a good response to this client's concerns. Since the client has been hospitalized for pharmacologic treatment, the need for multiple blood transfusions is unlikely. The medications do reverse the actions of chemotherapy against good cells, but this is a poor answer to the client and may cause undue stress. Chemotherapy is cytotoxic to rapidly proliferating cells